101 related articles for article (PubMed ID: 18760837)
21. Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.
Renneville A; Boissel N; Zurawski V; Llopis L; Biggio V; Nibourel O; Philippe N; Thomas X; Dombret H; Preudhomme C
Cancer; 2009 Aug; 115(16):3719-27. PubMed ID: 19536888
[TBL] [Abstract][Full Text] [Related]
22. Polymorphism in glutathione-S-transferases: a risk factor in alcoholic liver cirrhosis.
Khan AJ; Choudhuri G; Husain Q; Parmar D
Drug Alcohol Depend; 2009 May; 101(3):183-90. PubMed ID: 19157724
[TBL] [Abstract][Full Text] [Related]
23. DNA methylation analysis of ALOX12 and GSTM1 in acute myeloid leukaemia identifies prognostically significant groups.
Ohgami RS; Ma L; Ren L; Weinberg OK; Seetharam M; Gotlib JR; Arber DA
Br J Haematol; 2012 Oct; 159(2):182-90. PubMed ID: 22924777
[TBL] [Abstract][Full Text] [Related]
24. Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia.
Voso MT; Hohaus S; Guidi F; Fabiani E; D'Alò F; Groner S; Späth D; Doehner K; Leone G; Doehner H; Schlenk RF
Leukemia; 2008 Sep; 22(9):1685-91. PubMed ID: 18580952
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
26. Glutathione S-transferases (GSTT1 and GSTM1) genes polymorphisms and the treatment response and prognosis in Chinese patients with de novo acute myeloid leukemia.
Xiao Z; Yang L; Xu Z; Zhang Y; Liu L; Nie L; Li L; Wang J; Hao Y
Leuk Res; 2008 Aug; 32(8):1288-91. PubMed ID: 18035413
[TBL] [Abstract][Full Text] [Related]
27. GSTM1-null polymorphism as possible risk marker for hypertension: results from the aging and longevity study in the Sirente Geographic Area (ilSIRENTE study).
Capoluongo E; Onder G; Concolino P; Russo A; Santonocito C; Bernabei R; Zuppi C; Ameglio F; Landi F
Clin Chim Acta; 2009 Jan; 399(1-2):92-6. PubMed ID: 18840420
[TBL] [Abstract][Full Text] [Related]
28. Combined polymorphism analysis of glutathione S-transferase M1/G1 and interleukin-1B (IL-1B)/interleukin 1-receptor antagonist (IL-1RN) and gastric cancer risk in an Omani Arab Population.
Al-Moundhri MS; Alkindy M; Al-Nabhani M; Al-Bahrani B; Burney IA; Al-Habsi H; Ganguly SS; Tanira M
J Clin Gastroenterol; 2009 Feb; 43(2):152-6. PubMed ID: 18779738
[TBL] [Abstract][Full Text] [Related]
29. Association between glutathione S-transferase A1, M1 and T1 polymorphisms and hypertension.
Oniki K; Hori M; Takata K; Yokoyama T; Mihara S; Marubayashi T; Nakagawa K
Pharmacogenet Genomics; 2008 Mar; 18(3):275-7. PubMed ID: 18300949
[TBL] [Abstract][Full Text] [Related]
30. Effects of GSTT1, GSTM1 and GSTP1 gene polymorphism on the course of hepatitis B virus infection.
Kandemir O; Tamer L; Tasdelen B
Hepatogastroenterology; 2008; 55(86-87):1729-33. PubMed ID: 19102379
[TBL] [Abstract][Full Text] [Related]
31. An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review.
Mo Z; Gao Y; Cao Y; Gao F; Jian L
Prostate; 2009 May; 69(6):662-88. PubMed ID: 19143011
[TBL] [Abstract][Full Text] [Related]
32. GSTT1 and GSTM1 polymorphisms predict treatment outcome for acute myeloid leukemia: a systematic review and meta-analysis.
Xiao Q; Deng D; Li H; Ye F; Huang L; Zhang B; Ye B; Mo Z; Yang X; Liu Z
Ann Hematol; 2014 Aug; 93(8):1381-90. PubMed ID: 24994605
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients.
Kim DH; Lee NY; Lee MH; Sohn SK; Do YR; Park JY
Br J Haematol; 2008 Jan; 140(1):71-9. PubMed ID: 17983459
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of myeloperoxidase expression in childhood acute myeloid leukemia.
Roberson JR; Onciu M; Pounds S; Rubnitz JE; Pui CH; Razzouk BI
Pediatr Blood Cancer; 2008 Mar; 50(3):542-8. PubMed ID: 17763467
[TBL] [Abstract][Full Text] [Related]
35. Influence of genetic polymorphisms in GSTM1, GSTM3, GSTT1 and GSTP1 on allograft outcome in renal transplant recipients.
Singh R; Manchanda PK; Kesarwani P; Srivastava A; Mittal RD
Clin Transplant; 2009; 23(4):490-8. PubMed ID: 19486347
[TBL] [Abstract][Full Text] [Related]
36. The CYP1A1*2a allele is an independent prognostic factor for acute myeloid leukemia.
Voso MT; D'Alo' F; Gumiero D; Guidi F; Hohaus S; Leone G
Haematologica; 2005 Jul; 90(7):982-4. PubMed ID: 15996939
[TBL] [Abstract][Full Text] [Related]
37. C3435T polymorphism of the MDR1 gene is not associated with P-glycoprotein function of leukemic blasts and clinical outcome in patients with acute myeloid leukemia.
Hur EH; Lee JH; Lee MJ; Choi SJ; Lee JH; Kang MJ; Seol M; Jang YE; Lee HJ; Kang IS; Shim SK; Ryu SG; Kang YA; Lee YS; Park CJ; Chi HS; Lee KH
Leuk Res; 2008 Oct; 32(10):1601-4. PubMed ID: 18272218
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms of glutathione S-transferase mu1 (GSTM1) and theta 1 (GSTT1) genes in chronic myeloid leukaemia.
Lourenco GJ; Ortega MM; Nascimento H; Teori MT; De Souza CA; Costa FF; Lima CS
Eur J Haematol; 2005 Dec; 75(6):530-1. PubMed ID: 16313269
[No Abstract] [Full Text] [Related]
39. Polymorphism of glutathione S-transferases as genetic risk factors for the development of complications in type 2 diabetes mellitus.
Hossaini AM; Zamrroni IM; Kashem RA; Khan ZF
J Crit Care; 2008 Sep; 23(3):444-8. PubMed ID: 18725054
[TBL] [Abstract][Full Text] [Related]
40. GSTM1 and codon 72 P53 polymorphism in multiple myeloma.
Ortega MM; Honma HN; Zambon L; Lorand-Metze I; Costa FF; De Souza CA; Lima CS
Ann Hematol; 2007 Nov; 86(11):815-9. PubMed ID: 17653713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
